Literature DB >> 6017955

Mist tent therapy of the obstructive pulmonary lesion of cystic fibrosis.

L W Matthews, C F Doershuk, S Spector.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6017955

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  9 in total

1.  The myth of mist therapy.

Authors:  M Parmar
Journal:  Indian J Pediatr       Date:  1987 Sep-Oct       Impact factor: 1.967

2.  Influence of mist tent therapy on sputum viscosity and water content in cystic fibrosis.

Authors:  M Rosenbluth; V Chernick
Journal:  Arch Dis Child       Date:  1974-08       Impact factor: 3.791

Review 3.  Aerosol therapy in cystic fibrosis.

Authors:  M B Mearns
Journal:  Arch Dis Child       Date:  1970-10       Impact factor: 3.791

4.  Cystic fibrosis care-further considerations.

Authors:  C F Doershuck; L W Matthews; R C Stern; T F Boat
Journal:  Arch Dis Child       Date:  1972-12       Impact factor: 3.791

5.  Treatment and prevention of pulmonary complications of cystic fibrosis in infancy and early childhood.

Authors:  M B Mearns
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

6.  Ventilatory function in infants with cystic fibrosis. Physiological assessment of halation therapy.

Authors:  P D Phelan; M Gracey; H E Williams; C M Anderson
Journal:  Arch Dis Child       Date:  1969-06       Impact factor: 3.791

7.  Simple tests of ventilatory capacity in children with cystic fibrosis. I. Clinical and radiological findings in 85 patients. II. Three-year follow-up on 50 patients.

Authors:  M B Mearns
Journal:  Arch Dis Child       Date:  1968-10       Impact factor: 3.791

8.  Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.

Authors:  P H Weller; D Ingram; M A Preece; D J Matthew
Journal:  Thorax       Date:  1980-01       Impact factor: 9.139

9.  Effects of ultrasonic nebulization on pulmonary mechanics and blood gases in obstructive pulmonary disease.

Authors:  S Rao; M E Rose; A Rosenberg; B J Sproule
Journal:  Can Med Assoc J       Date:  1972-05-20       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.